Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.

Lowe DM, Rangaka MX, Gordon F, James CD, Miller RF.

PLoS One. 2013 Aug 2;8(8):e69969. doi: 10.1371/journal.pone.0069969. Print 2013. Review.

2.

Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: protocol for a systematic review.

Wasserman S, Engel ME, Mendelson M.

Syst Rev. 2013 Dec 12;2:112. doi: 10.1186/2046-4053-2-112.

3.

Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review.

Costiniuk CT, Fergusson DA, Doucette S, Angel JB.

PLoS One. 2011;6(12):e28570. doi: 10.1371/journal.pone.0028570. Epub 2011 Dec 16. Review.

4.

Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.

Hardak E, Neuberger A, Yigla M, Berger G, Finkelstein R, Sprecher H, Oren I.

Respirology. 2012 May;17(4):681-6. doi: 10.1111/j.1440-1843.2012.02158.x.

PMID:
22390188
5.

Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.

Mühlethaler K, Bögli-Stuber K, Wasmer S, von Garnier C, Dumont P, Rauch A, Mühlemann K, Garzoni C.

Eur Respir J. 2012 Apr;39(4):971-8. doi: 10.1183/09031936.00095811. Epub 2011 Sep 15.

6.
7.

Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia.

Davis JL, Welsh DA, Beard CB, Jones JL, Lawrence GG, Fox MR, Crothers K, Morris A, Charbonnet D, Swartzman A, Huang L.

Thorax. 2008 Apr;63(4):329-34. Epub 2007 Nov 16.

PMID:
18024536
8.

Pneumocystis jirovecii pneumonia in systemic lupus erythematosus from southern Taiwan.

Weng CT, Liu MF, Weng MY, Lee NY, Wang MC, Lin WC, Ou CY, Lai WW, Hsu SC, Chao SC, Chung TJ, Lee CT, Shieh CC, Wang JY, Wang CR.

J Clin Rheumatol. 2013 Aug;19(5):252-8. doi: 10.1097/RHU.0b013e31829d5017.

PMID:
23872548
9.

Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii.

Rostved AA, Sassi M, Kurtzhals JA, Sørensen SS, Rasmussen A, Ross C, Gogineni E, Huber C, Kutty G, Kovacs JA, Helweg-Larsen J.

Transplantation. 2013 Nov 15;96(9):834-42. doi: 10.1097/TP.0b013e3182a1618c.

10.

Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy.

Shankar SM, Nania JJ.

Paediatr Drugs. 2007;9(5):301-9.

PMID:
17927302
11.

Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.

Tasaka S, Tokuda H.

J Infect Chemother. 2012 Dec;18(6):793-806. doi: 10.1007/s10156-012-0453-0. Epub 2012 Aug 6. Review.

PMID:
22864454
12.

The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review.

Wu AK, Cheng VC, Tang BS, Hung IF, Lee RA, Hui DS, Yuen KY.

BMC Infect Dis. 2004 Dec 9;4(1):57. Review.

13.

Infrequent detection of Pneumocystis jirovecii by PCR in oral wash specimens from TB patients with or without HIV and healthy contacts in Tanzania.

Jensen L, Jensen AV, Praygod G, Kidola J, Faurholt-Jepsen D, Changalucha J, Range N, Friis H, Helweg-Larsen J, Jensen JS, Andersen AB.

BMC Infect Dis. 2010 May 28;10:140. doi: 10.1186/1471-2334-10-140.

14.

Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis.

Karageorgopoulos DE, Qu JM, Korbila IP, Zhu YG, Vasileiou VA, Falagas ME.

Clin Microbiol Infect. 2013 Jan;19(1):39-49. doi: 10.1111/j.1469-0691.2011.03760.x. Epub 2012 Feb 13.

15.

Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006.

Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF.

Clin Infect Dis. 2008 Feb 15;46(4):625-33. doi: 10.1086/526778.

16.

Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.

Hauser PM, Bille J, Lass-Flörl C, Geltner C, Feldmesser M, Levi M, Patel H, Muggia V, Alexander B, Hughes M, Follett SA, Cui X, Leung F, Morgan G, Moody A, Perlin DS, Denning DW.

J Clin Microbiol. 2011 May;49(5):1872-8. doi: 10.1128/JCM.02390-10. Epub 2011 Mar 2.

17.

Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.

Robert-Gangneux F, Belaz S, Revest M, Tattevin P, Jouneau S, Decaux O, Chevrier S, Le Tulzo Y, Gangneux JP.

J Clin Microbiol. 2014 Sep;52(9):3370-6. doi: 10.1128/JCM.01480-14. Epub 2014 Jul 9.

18.

Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection.

Enomoto T, Azuma A, Kohno A, Kaneko K, Saito H, Kametaka M, Usuki J, Gemma A, Kudoh S, Nakamura S.

Respirology. 2010 Jan;15(1):126-31. doi: 10.1111/j.1440-1843.2009.01660.x. Epub 2009 Nov 23.

PMID:
19947989
19.

[Positive Pneumocystis jirovecii PCR in immunocompromised patients with a systemic disease: infection or colonisation?].

Mekinian A, Queyrel V, Durand-Joly I, Moranne O, Denis G, Delhaes L, Morell-Dubois S, Lambert M, Launay D, Hachulla E, Hatron PY.

Rev Med Interne. 2010 Mar;31(3):194-9. doi: 10.1016/j.revmed.2009.11.007. Epub 2009 Dec 31. French.

PMID:
20045225
20.

Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients.

Djawe K, Huang L, Daly KR, Levin L, Koch J, Schwartzman A, Fong S, Roth B, Subramanian A, Grieco K, Jarlsberg L, Walzer PD.

PLoS One. 2010 Dec 9;5(12):e14259. doi: 10.1371/journal.pone.0014259.

Items per page

Supplemental Content

Write to the Help Desk